Principal Financial Group’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-14,666
| Closed | -$41.7K | – | 2368 |
|
|
2024
Q1 | $41.7K | Buy |
14,666
+194
| +1% | +$551 | ﹤0.01% | 2359 |
|
|
2023
Q4 | $213K | Buy |
14,472
+126
| +0.9% | +$1.86K | ﹤0.01% | 2155 |
|
|
2023
Q3 | $263K | Sell |
14,346
-332
| -2% | -$6.08K | ﹤0.01% | 2095 |
|
|
2023
Q2 | $317K | Sell |
14,678
-319
| -2% | -$6.88K | ﹤0.01% | 2067 |
|
|
2023
Q1 | $440K | Buy |
14,997
+1,484
| +11% | +$43.5K | ﹤0.01% | 1995 |
|
|
2022
Q4 | $499K | Buy |
+13,513
| New | +$499K | ﹤0.01% | 1976 |
|